Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 664,971
  • Shares Outstanding, K 272,529
  • Annual Sales, $ 200,520 K
  • Annual Income, $ -306,740 K
  • EBIT $ -318 M
  • EBITDA $ -304 M
  • 60-Month Beta 2.01
  • Price/Sales 2.95
  • Price/Cash Flow N/A
  • Price/Book 1.20

Options Overview Details

View History
  • Implied Volatility 131.39% ( +7.56%)
  • Historical Volatility 105.77%
  • IV Percentile 75%
  • IV Rank 48.97%
  • IV High 199.73% on 08/22/24
  • IV Low 65.82% on 11/07/23
  • Put/Call Vol Ratio 0.09
  • Today's Volume 11,361
  • Volume Avg (30-Day) 2,820
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 103,107
  • Open Int (30-Day) 101,244

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.20
  • Number of Estimates 4
  • High Estimate -0.16
  • Low Estimate -0.27
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +25.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.41 +72.44%
on 10/10/24
2.49 -2.20%
on 11/01/24
+0.82 (+50.62%)
since 10/01/24
3-Month
1.27 +92.13%
on 09/05/24
2.49 -2.20%
on 11/01/24
+0.52 (+27.08%)
since 08/01/24
52-Week
1.16 +110.34%
on 07/02/24
10.65 -77.09%
on 12/27/23
-3.53 (-59.13%)
since 11/01/23

Most Recent Stories

More News
PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500

PACB : 2.44 (+12.44%)
PacBio Onsoâ„¢ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program

PACB : 2.44 (+12.44%)
PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing

PACB : 2.44 (+12.44%)
PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024

PACB : 2.44 (+12.44%)
Pacific Biosciences: Q2 Earnings Snapshot

Pacific Biosciences: Q2 Earnings Snapshot

PACB : 2.44 (+12.44%)
Pacific Biosciences: Q1 Earnings Snapshot

Pacific Biosciences: Q1 Earnings Snapshot

PACB : 2.44 (+12.44%)
Pacific Biosciences: Q4 Earnings Snapshot

Pacific Biosciences: Q4 Earnings Snapshot

PACB : 2.44 (+12.44%)
Pacific Biosciences: Q3 Earnings Snapshot

Pacific Biosciences: Q3 Earnings Snapshot

PACB : 2.44 (+12.44%)
Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy?

This innovator is targeting a huge, rapidly growing market.

PACB : 2.44 (+12.44%)
ARKK : 46.64 (+1.63%)
ARKG : 24.00 (+3.72%)
PacBio Announces Appointment of David Meline to Board of Directors

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David...

PACB : 2.44 (+12.44%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 2.88
2nd Resistance Point 2.69
1st Resistance Point 2.56
Last Price 2.44
1st Support Level 2.25
2nd Support Level 2.06
3rd Support Level 1.93

See More

52-Week High 10.65
Fibonacci 61.8% 7.02
Fibonacci 50% 5.90
Fibonacci 38.2% 4.79
Last Price 2.44
52-Week Low 1.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar